Naltrexone and bupropion combination

DRUG2 trials

Sponsors

Yale University

Conditions

Binge Eating DisorderObesity

Phase 2

Pharmacological and Behavioral Treatment After Bariatric Surgery

RecruitingNCT05157698

Yale UniversityObesity

Start: 2022-01-13End: 2028-01-12Target: 160Updated: 2025-06-18

Unknown Phase

Treatment of Binge Eating Disorder in Obesity: Naltrexone/ Bupropion Combination Versus Placebo

CompletedNCT02317744

Yale UniversityBinge Eating Disorder

Start: 2014-12-31End: 2016-09-30Updated: 2017-12-22

Related Papers

Naltrexone + Bupropion Combination for the Treatment of Binge-eating Disorder with Obesity: A Randomized, Controlled Pilot Study.

2020-11-1836 citations